• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用增强 CT 对以实体成分为主的乏脂性肾细胞癌进行鉴别诊断:评估纹理在肿瘤分型中的作用。

Differentiation of Predominantly Solid Enhancing Lipid-Poor Renal Cell Masses by Use of Contrast-Enhanced CT: Evaluating the Role of Texture in Tumor Subtyping.

机构信息

1 Department of Radiology, University of Southern California, 1520 San Pablo St, HC2 L1600, Los Angeles, CA 90033.

2 Institute of Urology, University of Southern California, Los Angeles, CA.

出版信息

AJR Am J Roentgenol. 2018 Dec;211(6):W288-W296. doi: 10.2214/AJR.18.19551. Epub 2018 Sep 21.

DOI:10.2214/AJR.18.19551
PMID:30240299
Abstract

OBJECTIVE

The purpose of this study was to assess the accuracy of a panel of texture features extracted from clinical CT in differentiating benign from malignant solid enhancing lipid-poor renal masses.

MATERIALS AND METHODS

In a retrospective case-control study of 174 patients with predominantly solid nonmacroscopic fat-containing enhancing renal masses, 129 cases of malignant renal cell carcinoma were found, including clear cell, papillary, and chromophobe subtypes. Benign renal masses-oncocytoma and lipid-poor angiomyolipoma-were found in 45 patients. Whole-lesion ROIs were manually segmented and coregistered from the standard-of-care multiphase contrast-enhanced CT (CECT) scans of these patients. Pathologic diagnosis of all tumors was obtained after surgical resection. CECT images of the renal masses were used as inputs to a CECT texture analysis panel comprising 31 texture metrics derived with six texture methods. Stepwise logistic regression analysis was used to select the best predictor among all candidate predictors from each of the texture methods, and their performance was quantified by AUC.

RESULTS

Among the texture predictors aiding renal mass subtyping were entropy, entropy of fast-Fourier transform magnitude, mean, uniformity, information measure of correlation 2, and sum of averages. These metrics had AUC values ranging from good (0.80) to excellent (0.98) across the various subtype comparisons. The overall CECT-based tumor texture model had an AUC of 0.87 (p < 0.05) for differentiating benign from malignant renal masses.

CONCLUSION

The CT texture statistical model studied was accurate for differentiating benign from malignant solid enhancing lipid-poor renal masses.

摘要

目的

本研究旨在评估从临床 CT 提取的纹理特征对鉴别良恶性实性强化乏脂性肾脏肿块的准确性。

材料和方法

在对 174 例主要为实性、非肉眼含脂、强化的肾脏肿块的回顾性病例对照研究中,发现 129 例恶性肾细胞癌病例,包括透明细胞、乳头状和嫌色细胞亚型。良性肾脏肿块-嗜酸细胞瘤和乏脂性血管平滑肌脂肪瘤-在 45 例患者中发现。对这些患者的标准多期对比增强 CT(CECT)扫描进行手动分割和配准,获得全病灶 ROI。对所有肿瘤进行手术切除后的病理诊断。将肾脏肿块的 CECT 图像作为输入,使用包含 6 种纹理方法的 31 种纹理特征的 CECT 纹理分析面板。使用逐步逻辑回归分析从每个纹理方法的所有候选预测因子中选择最佳预测因子,并通过 AUC 对其性能进行量化。

结果

在辅助肾肿瘤亚型分类的纹理预测因子中包括熵、快速傅里叶变换幅度的熵、均值、均匀性、相关 2 信息测度和平均值之和。这些指标在各种亚型比较中的 AUC 值范围从良好(0.80)到优秀(0.98)。基于整个 CECT 的肿瘤纹理模型在区分良性和恶性肾脏肿块方面的 AUC 值为 0.87(p<0.05)。

结论

研究的 CT 纹理统计模型在区分良恶性实性强化乏脂性肾脏肿块方面具有准确性。

相似文献

1
Differentiation of Predominantly Solid Enhancing Lipid-Poor Renal Cell Masses by Use of Contrast-Enhanced CT: Evaluating the Role of Texture in Tumor Subtyping.采用增强 CT 对以实体成分为主的乏脂性肾细胞癌进行鉴别诊断:评估纹理在肿瘤分型中的作用。
AJR Am J Roentgenol. 2018 Dec;211(6):W288-W296. doi: 10.2214/AJR.18.19551. Epub 2018 Sep 21.
2
Differentiating solid, non-macroscopic fat containing, enhancing renal masses using fast Fourier transform analysis of multiphase CT.使用多期CT的快速傅里叶变换分析鉴别实性、不含肉眼可见脂肪、强化的肾肿块。
Br J Radiol. 2018 Sep;91(1089):20170789. doi: 10.1259/bjr.20170789. Epub 2018 Jun 21.
3
Deep learning based classification of solid lipid-poor contrast enhancing renal masses using contrast enhanced CT.基于深度学习的对比增强 CT 对固体脂质贫脂性增强性肾肿块的分类。
Br J Radiol. 2020 Jul;93(1111):20200002. doi: 10.1259/bjr.20200002. Epub 2020 May 11.
4
Automated classification of solid renal masses on contrast-enhanced computed tomography images using convolutional neural network with decision fusion.基于决策融合卷积神经网络的增强 CT 图像中肾脏实性肿块的自动分类。
Eur Radiol. 2020 Sep;30(9):5183-5190. doi: 10.1007/s00330-020-06787-9. Epub 2020 Apr 29.
5
Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.多期多层多排 CT 定量计算机辅助诊断算法在自动检测峰值病变衰减方面的应用,有助于鉴别透明细胞癌与乳头状癌、嫌色细胞癌、嗜酸细胞瘤、乏脂肪性血管平滑肌脂肪瘤。
Abdom Radiol (NY). 2017 Jul;42(7):1919-1928. doi: 10.1007/s00261-017-1095-6.
6
Differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma in contrast-enhanced MDCT images using quantitative feature classification.基于定量特征分类的 MDCT 增强图像鉴别乏脂性血管平滑肌脂肪瘤与透明细胞肾细胞癌
Med Phys. 2017 Jul;44(7):3604-3614. doi: 10.1002/mp.12258. Epub 2017 Jun 9.
7
Quantitative Contour Analysis as an Image-based Discriminator Between Benign and Malignant Renal Tumors.定量轮廓分析作为基于图像的肾良性与恶性肿瘤鉴别方法
Urology. 2018 Apr;114:121-127. doi: 10.1016/j.urology.2017.12.018. Epub 2018 Jan 2.
8
Texture analysis as a radiomic marker for differentiating renal tumors.纹理分析作为一种放射组学标志物用于区分肾肿瘤。
Abdom Radiol (NY). 2017 Oct;42(10):2470-2478. doi: 10.1007/s00261-017-1144-1.
9
Machine learning-based quantitative texture analysis of CT images of small renal masses: Differentiation of angiomyolipoma without visible fat from renal cell carcinoma.基于机器学习的小肾肿块 CT 图像定量纹理分析:无可见脂肪的血管平滑肌脂肪瘤与肾细胞癌的鉴别。
Eur Radiol. 2018 Apr;28(4):1625-1633. doi: 10.1007/s00330-017-5118-z. Epub 2017 Nov 13.
10
Usefulness of CT texture analysis in differentiating benign and malignant renal tumours.CT 纹理分析在鉴别良恶性肾肿瘤中的作用。
Clin Radiol. 2020 Feb;75(2):108-115. doi: 10.1016/j.crad.2019.09.131. Epub 2019 Oct 24.

引用本文的文献

1
Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Pathologic T3a Upstaging in Clinical T1 RCC.基于对比增强CT的影像组学列线图预测临床T1期肾细胞癌病理T3a期升级
Diagnostics (Basel). 2025 Feb 12;15(4):443. doi: 10.3390/diagnostics15040443.
2
Artificial intelligence for early detection of renal cancer in computed tomography: A review.计算机断层扫描中用于早期检测肾癌的人工智能:综述
Camb Prism Precis Med. 2022 Nov 11;1:e4. doi: 10.1017/pcm.2022.9. eCollection 2023.
3
The Use of Radiomic Tools in Renal Mass Characterization.
放射组学工具在肾肿物特征描述中的应用。
Diagnostics (Basel). 2023 Aug 24;13(17):2743. doi: 10.3390/diagnostics13172743.
4
Computer tomography-based shape of tumor contour and texture of tumor heterogeneity are independent prognostic indicators for clinical T1b-T2 renal cell carcinoma.计算机断层扫描(CT)成像下肿瘤轮廓的形状和肿瘤异质性的纹理是 T1b-T2 期肾细胞癌独立的预后指标。
World J Urol. 2023 Oct;41(10):2723-2734. doi: 10.1007/s00345-023-04543-4. Epub 2023 Aug 2.
5
Role of AI and Radiomic Markers in Early Diagnosis of Renal Cancer and Clinical Outcome Prediction: A Brief Review.人工智能与影像组学标志物在肾癌早期诊断及临床结局预测中的作用:简要综述
Cancers (Basel). 2023 May 19;15(10):2835. doi: 10.3390/cancers15102835.
6
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review.人工智能与影像组学在肾脏病变评估中的应用:一项综合文献综述
Ther Adv Urol. 2023 Apr 17;15:17562872231164803. doi: 10.1177/17562872231164803. eCollection 2023 Jan-Dec.
7
Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects.肾癌管理中的放射基因组学——当前证据和未来展望。
Int J Mol Sci. 2023 Feb 27;24(5):4615. doi: 10.3390/ijms24054615.
8
Advances in Imaging-Based Biomarkers in Renal Cell Carcinoma: A Critical Analysis of the Current Literature.肾细胞癌中基于成像的生物标志物研究进展:对当前文献的批判性分析
Cancers (Basel). 2023 Jan 5;15(2):354. doi: 10.3390/cancers15020354.
9
Distinguishing common renal cell carcinomas from benign renal tumors based on machine learning: comparing various CT imaging phases, slices, tumor sizes, and ROI segmentation strategies.基于机器学习鉴别常见肾细胞癌与良性肾肿瘤:比较不同 CT 成像期、层面、肿瘤大小和 ROI 分割策略。
Eur Radiol. 2023 Jun;33(6):4323-4332. doi: 10.1007/s00330-022-09384-0. Epub 2023 Jan 16.
10
Whole-Lesion CT Texture Analysis as a Quantitative Biomarker for the Identification of Homogeneous Renal Tumors.全病灶CT纹理分析作为识别均匀性肾肿瘤的定量生物标志物
Life (Basel). 2022 Dec 19;12(12):2148. doi: 10.3390/life12122148.